oral glp-1 medications fda approved A new chapter in treatment is here. Meet Foundayo™ by Eli Lilly, the first FDA-approved GLP-1, designed to support weight loss through a convenient once-daily approach. Prescription-only treatment, with instant With FDA approval of Wegovy

According to NICE guidance (NG145), the standard treatment is levothyroxine replacement therapy, with dose titration based on regular TSH monitoring, typically checking TSH 6-8 weeks after dose changes with the aim of achieving a TSH within the reference range

With the effects seen of the GLP-1 family of drugs on preventing kidney damage in diabetes, liver disease (non-alcoholic or metabolic-associated steatosis, NASH/MASH), and addiction, this drug class is exceeding all expectations

Taking it twice daily without provider direction could cause excessive gastrointestinal side effects including severe nausea and vomiting

Loss of bone mass is a concern, especially with getting fractures from falls, says Grunvald